Hyperkalemia during treatment with HMG-CoA reductase inhibitor.

[1]  J. Tobert.  Efficacy and long-term adverse effect pattern of lovastatin. , 1988, The American journal of cardiology.

[2]  S. Grundy.  HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. , 1988, The New England journal of medicine.

[3]  R. DeFronzo,et al.  Hyperkalemia and hyporeninemic hypoaldosteronism. , 1980, Kidney international.